| 1 | Uveal Neoplasms | 32.9% |
| 2 | Blepharitis | 27.8% |
| 3 | Blepharoptosis | 27.8% |
| 4 | Blepharospasm | 27.8% |
| 5 | Ectropion | 27.8% |
| 6 | Entropion | 27.8% |
| 7 | Trichiasis | 27.8% |
| 8 | Blepharophimosis | 27.7% |
| 9 | Retinal Degeneration | 22.4% |
| 10 | Asthenopia | 21.6% |
| 11 | Conjunctival Diseases | 21.6% |
| 12 | Corneal Diseases | 21.6% |
| 13 | Lacrimal Apparatus Diseases | 21.6% |
| 14 | Lens Diseases | 21.6% |
| 15 | Ocular Hypertension | 21.6% |
| 16 | Ocular Hypotension | 21.6% |
| 17 | Retinal Diseases | 21.6% |
| 18 | Scleral Diseases | 21.6% |
| 19 | Vitreous Detachment | 21.6% |
| 20 | Posterior Vitreous Detachment | 21.6% |
| 21 | Hordeolum | 21.4% |
| 22 | Retinoblastoma | 21% |
| 23 | Retinal Dysplasia | 20.8% |
| 24 | Eye Neoplasms | 19.4% |
| 25 | Xerophthalmia | 19.3% |
| 26 | Low Tension Glaucoma | 19.3% |
| 27 | Iridocorneal endothelial syndrome | 19.3% |
| 28 | Aniridia | 18.9% |
| 29 | Retinal Hemorrhage | 18.4% |
| 30 | Keratoconjunctivitis Sicca | 17.9% |
| 31 | Eye Abnormalities | 17.3% |
| 32 | Eye Infection | 17.3% |
| 33 | Eye Manifestations | 17.3% |
| 34 | Optic Neuropathy | 17.3% |
| 35 | Chorioretinitis | 17% |
| 36 | Keratoconjunctivitis | 16.3% |
| 37 | Corneal Ulcer | 16% |
| 38 | Choroid Hemorrhage | 15.9% |
| 39 | Pars Planitis | 15.8% |
| 40 | Duane Retraction Syndrome | 15.8% |
| 41 | Corneal Scar | 15.5% |
| 42 | Parathyroid Neoplasms | 14.8% |
| 43 | Thyroid Neoplasm | 14.8% |
| 44 | Thyroid carcinoma | 14.8% |
| 45 | Retinitis Pigmentosa | 14.8% |
| 46 | Pigmentary retinopathy | 14.8% |
| 47 | Mouth Neoplasms | 14.5% |
| 48 | Ocular Motility Disorders | 14.4% |
| 49 | Cyclophoria | 14.4% |
| 50 | Pupil Disorders | 14.2% |
| 51 | Choroiditis | 14.1% |
| 52 | Iridocyclitis | 14.1% |
| 53 | Iritis | 14.1% |
| 54 | Eye Hemorrhage | 14% |
| 55 | Vision Disorders | 14% |
| 56 | Metamorphopsia | 14% |
| 57 | Visual Impairment | 14% |
| 58 | Angioid Streaks | 13.9% |
| 59 | Anisometropia | 13.9% |
| 60 | Aphakia | 13.9% |
| 61 | Astigmatism | 13.9% |
| 62 | Choroid Diseases | 13.9% |
| 63 | Conjunctivitis | 13.9% |
| 64 | Corneal edema | 13.9% |
| 65 | Corneal Opacity | 13.9% |
| 66 | Dacryocystitis | 13.9% |
| 67 | Dry Eye Syndromes | 13.9% |
| 68 | Enophthalmos | 13.9% |
| 69 | Episcleritis | 13.9% |
| 70 | Exophthalmos | 13.9% |
| 71 | Glaucoma | 13.9% |
| 72 | Iris Diseases | 13.9% |
| 73 | Keratitis | 13.9% |
| 74 | Keratoconus | 13.9% |
| 75 | Lacrimal Duct Obstruction | 13.9% |
| 76 | Lens dislocation | 13.9% |
| 77 | Lens Subluxation | 13.9% |
| 78 | Mydriasis | 13.9% |
| 79 | Myopia | 13.9% |
| 80 | Presbyopia | 13.9% |
| 81 | Pterygium | 13.9% |
| 82 | Retinal Detachment | 13.9% |
| 83 | Retinitis | 13.9% |
| 84 | Scleritis | 13.9% |
| 85 | Uveitis | 13.9% |
| 86 | Corneal Neovascularization | 13.9% |
| 87 | Orbital Pseudotumor | 13.9% |
| 88 | Cataract | 13.9% |
| 89 | Pinguecula | 13.9% |
| 90 | Eye Injuries | 13.9% |
| 91 | Color blindness | 13.5% |
| 92 | Trachoma | 13.3% |
| 93 | Tracheal Neoplasms | 13.2% |
| 94 | Abdominal Neoplasms | 13% |
| 95 | Soft Tissue Neoplasms | 13% |
| 96 | Thoracic Neoplasms | 13% |
| 97 | Acanthamoeba Keratitis | 11.7% |
| 98 | Keratitis, Herpetic | 11.7% |
| 99 | Cytomegalovirus Retinitis | 11.7% |
| 100 | Bacterial conjunctivitis | 11.5% |
| 101 | Corneal Perforation | 11.4% |
| 102 | Esophageal Neoplasms | 11.3% |
| 103 | Anophthalmos | 11% |
| 104 | Endophthalmitis | 11% |
| 105 | Microphthalmos | 11% |
| 106 | Optic Atrophy | 11% |
| 107 | Optic Neuritis | 11% |
| 108 | Papilledema | 11% |
| 109 | Pemphigoid, Benign Mucous Membrane | 11% |
| 110 | Retinal Artery Occlusion | 11% |
| 111 | Retinopathy of Prematurity | 11% |
| 112 | Strabismus | 11% |
| 113 | Tolosa-Hunt Syndrome | 11% |
| 114 | Orbital Cellulitis | 11% |
| 115 | Retinal Vasculitis | 11% |
| 116 | Hypertensive Retinopathy | 11% |
| 117 | Retrobulbar Hemorrhage | 11% |
| 118 | Corneal Endothelial Cell Loss | 11% |
| 119 | Hyphema | 11% |
| 120 | Retinal Neovascularization | 11% |
| 121 | Vitreous Hemorrhage | 11% |
| 122 | Eyelid Diseases | 10.8% |
| 123 | Digestive System Neoplasms | 10.8% |
| 124 | Endocrine Gland Neoplasms | 10.8% |
| 125 | Nervous System Neoplasms | 10.8% |
| 126 | Bone neoplasms | 10.5% |
| 127 | Skin Neoplasms | 10.5% |
| 128 | Hematologic Neoplasms | 10.5% |
| 129 | Splenic Neoplasms | 10.3% |
| 130 | Angle Closure Glaucoma | 10.3% |
| 131 | Glaucoma, Open-Angle | 10.3% |
| 132 | Macular degeneration | 10.3% |
| 133 | Panuveitis | 10.3% |
| 134 | Retinal Drusen | 10.3% |
| 135 | Retinal Necrosis Syndrome, Acute | 10.3% |
| 136 | Retinoschisis | 10.3% |
| 137 | Exfoliation Syndrome | 10.3% |
| 138 | Panophthalmitis | 9.8% |
| 139 | Thyroid Nodule | 9.6% |
| 140 | Optic Neuropathy, Ischemic | 9.2% |
| 141 | Anterior Ischemic Optic Neuropathy | 9.2% |
| 142 | Eyelid Neoplasms | 9.2% |
| 143 | Retinal Vein Occlusion | 9.2% |
| 144 | Anisocoria | 9.1% |
| 145 | Diabetic Retinopathy | 9.1% |
| 146 | Tonic Pupil | 9.1% |
| 147 | Eye pain | 9.1% |
| 148 | Orbital Myositis | 9.1% |
| 149 | Diplopia | 9% |
| 150 | Scotoma | 9% |
| 151 | Photophobia | 9% |
| 152 | Amaurosis | 9% |
| 153 | Blindness | 9% |
| 154 | Peritoneal Neoplasms | 8.9% |
| 155 | Anterior uveitis | 8.5% |
| 156 | Uveitis, Posterior | 8.5% |
| 157 | Opsoclonus-Myoclonus Syndrome | 8.4% |
| 158 | Multiple Endocrine Neoplasia | 8.2% |
| 159 | Leukoplakia, Oral | 8.2% |
| 160 | Esotropia | 8.1% |
| 161 | Exotropia | 8.1% |
| 162 | Hamartoma | 8.1% |
| 163 | Neoplasms, Hormone-Dependent | 8.1% |
| 164 | Neoplasms, Multiple Primary | 8.1% |
| 165 | Paraneoplastic Syndromes | 8.1% |
| 166 | Precancerous Conditions | 8.1% |
| 167 | Neoplasms, Second Primary | 8.1% |
| 168 | Choroidal Neovascularization | 8.1% |
| 169 | Paraneoplastic Encephalomyelitis | 8.1% |
| 170 | Ear Neoplasms | 8% |
| 171 | Mammary Neoplasms, Experimental | 8% |
| 172 | Salivary Gland Neoplasms | 7.9% |
| 173 | Tongue Neoplasms | 7.9% |
| 174 | Pancreatic Neoplasm | 7.8% |
| 175 | Ophthalmoplegia | 7.8% |
| 176 | External Ophthalmoplegia | 7.8% |
| 177 | Amblyopia | 7.7% |
| 178 | Retroperitoneal Neoplasms | 7.7% |
| 179 | Acanthoma | 7.4% |
| 180 | Ophthalmia Neonatorum | 7.4% |
| 181 | Optic Atrophy, Hereditary, Leber | 7.3% |
| 182 | Pharyngeal Neoplasms | 6.9% |
| 183 | Uveomeningoencephalitic Syndrome | 6.9% |
| 184 | CHARGE Syndrome | 6.9% |
| 185 | Nose Neoplasms | 6.8% |
| 186 | Palatal Neoplasms | 6.8% |
| 187 | Congenital nystagmus | 6.8% |
| 188 | Herpes Zoster Ophthalmicus | 6.8% |
| 189 | Hemianopsia | 6.7% |
| 190 | Amaurosis Fugax | 6.7% |
| 191 | Blindness, Cortical | 6.7% |
| 192 | Cyst | 6.5% |
| 193 | Neoplastic Processes | 6.5% |
| 194 | Neoplastic Syndromes, Hereditary | 6.5% |
| 195 | Pregnancy Complications, Neoplastic | 6.5% |
| 196 | Neoplasms, Experimental | 6.4% |
| 197 | Central Nervous System Neoplasms | 6.2% |
| 198 | Vascular Neoplasms | 6.2% |
| 199 | Thymus Neoplasms | 6.2% |
| 200 | Genital Neoplasms, Female | 6.1% |
| 201 | Laryngeal neoplasm | 6.1% |
| 202 | Breast Neoplasms, Male | 6.1% |
| 203 | Triple Negative Breast Neoplasms | 6.1% |
| 204 | Optic Nerve Glioma | 6.1% |
| 205 | Aicardi's syndrome | 6.1% |
| 206 | Carcinoma, Lobular | 5.9% |
| 207 | Graves Disease | 5.9% |
| 208 | Horner Syndrome | 5.8% |
| 209 | Mandibulofacial Dysostosis | 5.7% |
| 210 | Testicular Neoplasms | 5.6% |
| 211 | Albinism | 5.4% |
| 212 | Neoplasms, Radiation-Induced | 5.3% |
| 213 | Adrenal Gland Neoplasms | 5.2% |
| 214 | Gastrointestinal Neoplasms | 5.2% |
| 215 | Genital Neoplasms, Male | 5.2% |
| 216 | Liver neoplasms | 5.2% |
| 217 | Urologic Neoplasms | 5.1% |
| 218 | Sebaceous Gland Neoplasms | 5.1% |
| 219 | Spinal Neoplasms | 5.1% |
| 220 | Bone Marrow Neoplasms | 5.1% |
| 221 | Thymoma | 5.1% |
| 222 | Hypopharyngeal Neoplasms | 5% |
| 223 | Hypopharyngeal Cancer | 5% |
| 224 | Multiple Endocrine Neoplasia Type 1 | 5% |
| 225 | Meningioma | 5% |
| 226 | Parotid Neoplasms | 5% |
| 227 | Carcinoma, Pancreatic Ductal | 4.9% |
| 228 | Miller Fisher Syndrome | 4.8% |
| 229 | Carcinoma, Ehrlich Tumor | 4.8% |
| 230 | Dermoid Cyst | 4.8% |
| 231 | Carcinoma, Lewis Lung | 4.8% |
| 232 | Carcinoma 256, Walker | 4.8% |
| 233 | Kearns-Sayre syndrome | 4.8% |
| 234 | Liver Neoplasms, Experimental | 4.6% |
| 235 | Trophoblastic Neoplasms | 4.6% |
| 236 | Leukemia, Experimental | 4.5% |
| 237 | Sicca Syndrome | 4.4% |
| 238 | Sjogren's Syndrome | 4.4% |
| 239 | Erythroplasia | 4.3% |
| 240 | Follicular cyst | 4.3% |
| 241 | leukemia | 4.3% |
| 242 | Mucocele | 4.3% |
| 243 | Neoplasms, Germ Cell and Embryonal | 4.3% |
| 244 | Neoplasms, Glandular and Epithelial | 4.3% |
| 245 | Pilonidal Cyst | 4.3% |
| 246 | Thyroglossal Cyst | 4.3% |
| 247 | Synovial Cyst | 4.3% |
| 248 | Germ Cell Cancer | 4.3% |
| 249 | Aberrant Crypt Foci | 4.3% |
| 250 | Paraneoplastic Cerebellar Degeneration | 4.3% |
| 251 | Tuberous Sclerosis | 4.3% |
| 252 | Tonsillar Neoplasms | 4.1% |
| 253 | Neuroectodermal Tumors | 4.1% |
| 254 | Meningeal Neoplasms | 4.1% |
| 255 | Ophthalmoplegic Migraine | 4% |
| 256 | Progressive supranuclear palsy | 4% |
| 257 | Sarcoma, Experimental | 4% |
| 258 | Melanoma, Experimental | 4% |
| 259 | Leukemia, Radiation-Induced | 3.9% |
| 260 | Acoustic Neuroma | 3.9% |
| 261 | Nasopharyngeal Neoplasms | 3.9% |
| 262 | Neoplasms, Neuroepithelial | 3.9% |
| 263 | Gliomatosis cerebri | 3.9% |
| 264 | Hepatocellular Adenoma | 3.8% |
| 265 | insulinoma | 3.8% |
| 266 | ovarian neoplasm | 3.8% |
| 267 | Nephroblastoma | 3.8% |
| 268 | Vipoma | 3.8% |
| 269 | Limbic Encephalitis | 3.7% |
| 270 | Pituitary Adenoma | 3.7% |
| 271 | Pituitary Neoplasms | 3.7% |
| 272 | Gastrinoma | 3.7% |
| 273 | Glucagonoma | 3.7% |
| 274 | Neuromyelitis Optica | 3.6% |
| 275 | Nasopharyngeal carcinoma | 3.5% |
| 276 | Paranasal Sinus Neoplasms | 3.5% |
| 277 | Leukoplakia | 3.5% |
| 278 | Lymphocele | 3.5% |
| 279 | Pancreatic Cyst | 3.5% |
| 280 | Barrett Esophagus | 3.4% |
| 281 | Breast Cyst | 3.4% |
| 282 | Histiocytic Disorders, Malignant | 3.4% |
| 283 | Actinic keratosis | 3.4% |
| 284 | Lung Neoplasms | 3.4% |
| 285 | Mediastinal Cyst | 3.4% |
| 286 | Neoplasm Invasiveness | 3.4% |
| 287 | Neoplasm Metastasis | 3.4% |
| 288 | Neoplasm Recurrence, Local | 3.4% |
| 289 | Parovarian Cyst | 3.4% |
| 290 | Pericardial Cyst | 3.4% |
| 291 | Pleural Neoplasms | 3.4% |
| 292 | Thymic Cyst | 3.4% |
| 293 | Carcinogenesis | 3.4% |
| 294 | Myxoid cyst | 3.4% |
| 295 | Metastasis | 3.4% |
| 296 | Lambert-Eaton Myasthenic Syndrome | 3.4% |
| 297 | Carcinosarcoma | 3.4% |
| 298 | Hemangiosarcoma | 3.4% |
| 299 | Leukemia L1210 | 3.4% |
| 300 | Leukemia P388 | 3.4% |
| 301 | lymphangiosarcoma | 3.4% |
| 302 | Brain Neoplasms | 3.4% |
| 303 | Spinal Cord Neoplasms | 3.4% |
| 304 | Behcet Syndrome | 3.4% |
| 305 | melanoma | 3.3% |
| 306 | Uterine Neoplasms | 3.3% |
| 307 | Vaginal Neoplasms | 3.3% |
| 308 | Vulvar Neoplasms | 3.3% |
| 309 | Uterine Cancer | 3.3% |
| 310 | Fallopian Tube Neoplasms | 3.3% |
| 311 | Prolactinoma | 3.3% |
| 312 | Growth Hormone-Secreting Pituitary Adenoma | 3.3% |
| 313 | Alstrom Syndrome | 3.3% |
| 314 | Leydig Cell Tumor | 3.2% |
| 315 | Lymphomatoid Granulomatosis | 3.1% |
| 316 | Choriocarcinoma | 3.1% |
| 317 | Sarcoma 180 | 3% |
| 318 | Meningeal Carcinomatosis | 3% |
| 319 | granulosa cell tumor | 2.9% |
| 320 | Carcinoma, Ovarian Epithelial | 2.9% |
| 321 | Central Nervous System Cysts | 2.9% |
| 322 | Medulloblastoma | 2.9% |
| 323 | Bile Duct Neoplasms | 2.9% |
| 324 | gallbladder neoplasm | 2.9% |
| 325 | Intestinal Neoplasms | 2.9% |
| 326 | Penile Neoplasms | 2.9% |
| 327 | Prostatic Neoplasms | 2.9% |
| 328 | Stomach Neoplasms | 2.9% |
| 329 | Maxillary Sinus Neoplasms | 2.9% |
| 330 | Composite Lymphoma | 2.9% |
| 331 | Lymphoma | 2.9% |
| 332 | Polycythemia Vera | 2.8% |
| 333 | Corpus Luteum Cyst | 2.8% |
| 334 | Ovarian Cysts | 2.8% |
| 335 | Adenomatous Polyposis Coli | 2.8% |
| 336 | Leukemia, Plasma Cell | 2.8% |
| 337 | Adenoma, Acidophil | 2.8% |
| 338 | Ganglioneuroma | 2.8% |
| 339 | Glioma | 2.8% |
| 340 | Malignant Glioma | 2.8% |
| 341 | Mesoblastic Nephroma | 2.7% |
| 342 | Myelitis, Transverse | 2.7% |
| 343 | Basal cell carcinoma | 2.7% |
| 344 | Carcinoma, Papillary | 2.7% |
| 345 | Squamous cell carcinoma | 2.7% |
| 346 | Chondrosarcoma | 2.7% |
| 347 | Craniopharyngioma | 2.7% |
| 348 | Cystadenoma | 2.7% |
| 349 | leiomyosarcoma | 2.7% |
| 350 | liposarcoma | 2.7% |
| 351 | Mesothelioma | 2.7% |
| 352 | synovial sarcoma | 2.7% |
| 353 | Neuroectodermal Tumor, Melanotic | 2.7% |
| 354 | Angiomyolipoma | 2.7% |
| 355 | Clear Cell Sarcoma of Soft Tissue | 2.7% |
| 356 | Alveolar Soft Part Sarcoma | 2.7% |
| 357 | Neuroendocrine Tumors | 2.7% |
| 358 | Sarcoma, Myeloid | 2.7% |
| 359 | Carcinoma, Basal Cell | 2.7% |
| 360 | Basal Cell Nevus Syndrome | 2.6% |
| 361 | Adenoma | 2.6% |
| 362 | Ameloblastoma | 2.6% |
| 363 | Angiokeratoma | 2.6% |
| 364 | Carcinoma | 2.6% |
| 365 | Chordoma | 2.6% |
| 366 | Hemangioma | 2.6% |
| 367 | hemangiopericytoma | 2.6% |
| 368 | Lymphangioma | 2.6% |
| 369 | Mesenchymoma | 2.6% |
| 370 | Nevus | 2.6% |
| 371 | Teratoma | 2.6% |
| 372 | Hepatoblastoma | 2.6% |
| 373 | Mixed Tumor, Mullerian | 2.6% |
| 374 | Germinoma | 2.6% |
| 375 | Teratocarcinoma | 2.6% |
| 376 | Angiofibroma | 2.6% |
| 377 | Sarcoma | 2.6% |
| 378 | Epithelioma | 2.6% |
| 379 | Bronchial Neoplasms | 2.5% |
| 380 | Multiple Pulmonary Nodules | 2.5% |
| 381 | Bladder Neoplasm | 2.5% |
| 382 | Kidney Neoplasm | 2.5% |
| 383 | Ureteral Neoplasms | 2.5% |
| 384 | Urethral Neoplasms | 2.5% |
| 385 | Supratentorial Neoplasms | 2.5% |
| 386 | Carcinoid Tumor | 2.5% |
| 387 | Endometrial Neoplasms | 2.5% |
| 388 | Neurilemmoma | 2.5% |
| 389 | Hutchinson's Melanotic Freckle | 2.5% |
| 390 | Melanoma, Amelanotic | 2.5% |
| 391 | Adrenocortical carcinoma | 2.5% |
| 392 | Choledochal Cyst | 2.5% |
| 393 | Peutz-Jeghers Syndrome | 2.4% |
| 394 | Cystadenocarcinoma | 2.3% |
| 395 | Fibrosarcoma | 2.3% |
| 396 | Osteosarcoma | 2.3% |
| 397 | Mucoepidermoid Carcinoma | 2.3% |
| 398 | Astrocytoma | 2.2% |
| 399 | Ependymoma | 2.2% |
| 400 | oligodendroglioma | 2.2% |
| 401 | Ganglioglioma | 2.2% |
| 402 | gliosarcoma | 2.2% |
| 403 | Anaplastic astrocytoma | 2.2% |
| 404 | Anaplastic Oligodendroglioma | 2.2% |
| 405 | Renal Cell Carcinoma | 2.2% |
| 406 | Papillary Renal Cell Carcinoma | 2.2% |
| 407 | Adenofibroma | 2.2% |
| 408 | Fibroadenoma | 2.2% |
| 409 | Malignant Fibrous Histiocytoma | 2.2% |
| 410 | Pleural Effusion, Malignant | 2.2% |
| 411 | Prostatic Neoplasms, Castration-Resistant | 2.1% |
| 412 | Endometrial Stromal Sarcoma | 2.1% |
| 413 | Nelson Syndrome | 2.1% |
| 414 | Brain Stem Neoplasms | 2.1% |
| 415 | Malignant Carcinoid Syndrome | 2.1% |
| 416 | Pancreatic Pseudocyst | 2% |
| 417 | Plasmacytoma | 2% |
| 418 | Malignant histiocytosis | 2% |
| 419 | Lymphatic Metastasis | 2% |
| 420 | Neoplasms, Unknown Primary | 2% |
| 421 | Leukemic Infiltration | 2% |
| 422 | Histiocytic sarcoma | 2% |
| 423 | Neoplasm Micrometastasis | 2% |
| 424 | Bowen's Disease | 2% |
| 425 | Paraganglioma | 2% |
| 426 | Rhabdomyosarcoma | 2% |
| 427 | Giant Cell Tumor of Bone | 2% |
| 428 | Hydatidiform Mole | 1.9% |
| 429 | Glioblastoma | 1.9% |
| 430 | Neuroblastoma | 1.9% |
| 431 | Glioblastoma Multiforme | 1.9% |
| 432 | Carcinoma, Endometrioid | 1.9% |
| 433 | Lymphangioleiomyomatosis | 1.9% |
| 434 | Denys-Drash Syndrome | 1.9% |
| 435 | Cecal Neoplasms | 1.9% |
| 436 | Duodenal Neoplasms | 1.9% |
| 437 | Choroid Plexus Papilloma | 1.9% |
| 438 | Dermatofibrosarcoma | 1.8% |
| 439 | Dermatofibrosarcoma Protuberans | 1.8% |
| 440 | Ganglioneuroblastoma | 1.8% |
| 441 | Cerebellar Neoplasms | 1.8% |
| 442 | Neurofibrosarcoma | 1.7% |
| 443 | Adenocarcinoma | 1.7% |
| 444 | Carcinoma in Situ | 1.7% |
| 445 | Carcinoma, Transitional Cell | 1.7% |
| 446 | Phyllodes Tumor | 1.7% |
| 447 | Dysgerminoma | 1.7% |
| 448 | Hemangioendothelioma | 1.7% |
| 449 | Lipoma | 1.7% |
| 450 | Myoma | 1.7% |
| 451 | Myxoma | 1.7% |
| 452 | Neuroma | 1.7% |
| 453 | Papilloma | 1.7% |
| 454 | Pseudomyxoma Peritonei | 1.7% |
| 455 | Seminoma | 1.7% |
| 456 | Papillomatosis | 1.7% |
| 457 | Angiolipoma | 1.7% |
| 458 | Myelolipoma | 1.7% |
| 459 | Neoplasms, Bone Tissue | 1.7% |
| 460 | Neoplasms, Fibrous Tissue | 1.7% |
| 461 | Smooth Muscle Tumor | 1.7% |
| 462 | Adenomatosis, Pulmonary | 1.7% |
| 463 | Adenomatous Polyps | 1.7% |
| 464 | Carcinoma, Large Cell | 1.7% |
| 465 | Carcinoma, Small Cell | 1.7% |
| 466 | Desmoplastic Small Round Cell Tumor | 1.7% |
| 467 | Chondroma | 1.7% |
| 468 | Enchondroma | 1.7% |
| 469 | Hodgkin Disease | 1.7% |
| 470 | Lymphoma, Non-Hodgkin | 1.7% |
| 471 | Polycystic Ovary Syndrome | 1.7% |
| 472 | Pheochromocytoma | 1.7% |
| 473 | Alveolar rhabdomyosarcoma | 1.7% |
| 474 | Colorectal Neoplasms | 1.6% |
| 475 | Carcinoid Heart Disease | 1.6% |
| 476 | Xeroderma Pigmentosum | 1.5% |
| 477 | Appendiceal Neoplasms | 1.5% |
| 478 | Colonic Neoplasms | 1.5% |
| 479 | Rectal Neoplasms | 1.5% |
| 480 | Primary amyloidosis | 1.4% |
| 481 | Leukemia, Myelomonocytic, Chronic | 1.3% |
| 482 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 1.3% |
| 483 | Adenoid Cystic Carcinoma | 1.3% |
| 484 | fibroma | 1.3% |
| 485 | Fibromatosis | 1.3% |
| 486 | Osteoblastoma | 1.3% |
| 487 | Osteoma | 1.3% |
| 488 | Rhabdomyoma | 1.3% |
| 489 | Chondromatosis | 1.3% |
| 490 | Adenocarcinoma, Clear Cell | 1.3% |
| 491 | Cholangiocarcinoma | 1.3% |
| 492 | Cervical Intraepithelial Neoplasia | 1.3% |
| 493 | Hemangioblastoma | 1.3% |
| 494 | Lymphoma, Extranodal NK-T-Cell | 1.3% |
| 495 | Anus Neoplasms | 1.2% |
| 496 | Sigmoid Neoplasms | 1.2% |
| 497 | Mastocytosis | 1.1% |
| 498 | Sturge-Weber Syndrome | 1.1% |
| 499 | Cell Transformation, Viral | 1.1% |
| 500 | Gastrointestinal Stromal Tumors | 1.1% |
| 501 | Hemangioma, Cavernous | 1.1% |
| 502 | Waldenstrom Macroglobulinemia | 1.1% |
| 503 | Multiple Myeloma | 1.1% |
| 504 | Leukemia, T-Cell | 1.1% |
| 505 | Leukemia, B-Cell | 1.1% |
| 506 | neurofibroma | 1.1% |
| 507 | Lymphoma, Follicular | 1.1% |
| 508 | T-Cell Lymphoma | 1.1% |
| 509 | Mantle cell lymphoma | 1.1% |
| 510 | Fibromatosis, Aggressive | 1.1% |
| 511 | Fibromatosis, Abdominal | 1.1% |
| 512 | Klatskin Tumor | 1.1% |
| 513 | Mastocytoma | 1% |
| 514 | Mastocytosis, Systemic | 1% |
| 515 | Zollinger-Ellison syndrome | 1% |
| 516 | Leukemia, Myeloid, Chronic-Phase | 1% |
| 517 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 0.8% |
| 518 | Leukemia, Large Granular Lymphocytic | 0.8% |
| 519 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 0.8% |
| 520 | Lymphoma, T-Cell, Cutaneous | 0.8% |
| 521 | Lymphoma, AIDS-Related | 0.8% |
| 522 | Enteropathy-Associated T-Cell Lymphoma | 0.8% |
| 523 | Primary Effusion Lymphoma | 0.8% |
| 524 | Dupuytren Contracture | 0.7% |
| 525 | Urticaria Pigmentosa | 0.7% |
| 526 | Mycosis Fungoides | 0.7% |
| 527 | Lymphomatoid Papulosis | 0.7% |
| 528 | Plasmablastic lymphoma | 0.7% |
| 529 | Burkitt Lymphoma | 0.6% |
| 530 | Sezary Syndrome | 0.5% |
| 531 | Radicular Cyst | 0.5% |